{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:24:13Z","timestamp":1707524653497},"reference-count":36,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,10,18]]},"DOI":"10.7759\/cureus.30412","type":"journal-article","created":{"date-parts":[[2022,10,18]],"date-time":"2022-10-18T08:50:17Z","timestamp":1666083017000},"source":"Crossref","is-referenced-by-count":0,"title":["A Review of Proteins Associated With Neuroprotection and Regeneration in Alzheimer's Disease"],"prefix":"10.7759","author":[{"given":"Harshita","family":"Agrawal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashok M","family":"Mehendale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-021-00269-y","article-title":"Alzheimer disease","volume":"7","author":"Knopman DS","year":"2021","unstructured":"Knopman DS, Amieva H, Petersen RC, et al.. Alzheimer disease. Nat Rev Dis Primers. 2021, 7:33. 10.1038\/s41572-021-00269-y","journal-title":"Nat Rev Dis Primers"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1002\/alz.12328","article-title":"2021 Alzheimer's disease facts and figures","volume":"14","author":"Alzheimer's Association","year":"2021","unstructured":"Alzheimer's Association. 2021 Alzheimer's disease facts and figures. Alzheimers Dement. 2021, 14:327-406. 10.1002\/alz.12328","journal-title":"Alzheimers Dement"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s11011-021-00847-9","article-title":"Promising protein biomarkers in the early diagnosis of Alzheimer's disease","volume":"37","author":"Sharma L","year":"2022","unstructured":"Sharma L, Sharma A, Kumar D, et al.. Promising protein biomarkers in the early diagnosis of Alzheimer's disease. Metab Brain Dis. 2022, 37:1727-44. 10.1007\/s11011-021-00847-9","journal-title":"Metab Brain Dis"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.31887\/DCNS.2000.2.2\/asschachter","article-title":"Alzheimer's disease","volume":"2","author":"Schachter AS","year":"2000","unstructured":"Schachter AS, Davis KL. Alzheimer's disease. Dialogues Clin Neurosci. 2000, 2:91-100. 10.31887\/DCNS.2000.2.2\/asschachter","journal-title":"Dialogues Clin Neurosci"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2013.80","article-title":"Secreted calmodulin-like skin protein inhibits neuronal death in cell-based Alzheimer's disease models via the heterotrimeric humanin receptor","volume":"4","author":"Hashimoto Y","year":"2013","unstructured":"Hashimoto Y, Nawa M, Kurita M, Tokizawa M, Iwamatsu A, Matsuoka M. Secreted calmodulin-like skin protein inhibits neuronal death in cell-based Alzheimer's disease models via the heterotrimeric humanin receptor. Cell Death Dis. 2013, 4:e555. 10.1038\/cddis.2013.80","journal-title":"Cell Death Dis"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.0575-06.2006","article-title":"Neuronal pentraxin 1 contributes to the neuronal damage evoked by amyloid-beta and is overexpressed in dystrophic neurites in Alzheimer's brain","volume":"26","author":"Abad MA","year":"2006","unstructured":"Abad MA, Enguita M, DeGregorio-Rocasolano N, Ferrer I, Trullas R. Neuronal pentraxin 1 contributes to the neuronal damage evoked by amyloid-beta and is overexpressed in dystrophic neurites in Alzheimer's brain. J Neurosci. 2006, 26:12735-47. 10.1523\/JNEUROSCI.0575-06.2006","journal-title":"J Neurosci"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.str.2006.04.004","article-title":"A structural and dynamic characterization of the EF-hand protein CLSP","volume":"14","author":"Babini E","year":"2006","unstructured":"Babini E, Bertini I, Capozzi F, Chirivino E, Luchinat C. A structural and dynamic characterization of the EF-hand protein CLSP. Structure. 2006, 14:1029-38. 10.1016\/j.str.2006.04.004","journal-title":"Structure"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1080\/01616412.2017.1335458","article-title":"Calmodulin-like skin protein is downregulated in human cerebrospinal fluids of Alzheimer's disease patients with apolipoprotein E4; a pilot study using postmortem samples","volume":"39","author":"Hashimoto Y","year":"2017","unstructured":"Hashimoto Y, Umahara T, Hanyu H, Iwamoto T, Matsuoka M. Calmodulin-like skin protein is downregulated in human cerebrospinal fluids of Alzheimer's disease patients with apolipoprotein E4; a pilot study using postmortem samples. Neurol Res. 2017, 39:767-72. 10.1080\/01616412.2017.1335458","journal-title":"Neurol Res"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-014-8799-1","article-title":"Protective effects of humanin and calmodulin-like skin protein in Alzheimer's disease and broad range of abnormalities","volume":"51","author":"Matsuoka M","year":"2015","unstructured":"Matsuoka M. Protective effects of humanin and calmodulin-like skin protein in Alzheimer's disease and broad range of abnormalities. Mol Neurobiol. 2015, 51:1232-9. 10.1007\/s12035-014-8799-1","journal-title":"Mol Neurobiol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/jnc.14258","article-title":"Calmodulin-like skin protein protects against spatial learning impairment in a mouse model of Alzheimer disease","volume":"144","author":"Kusakari S","year":"2018","unstructured":"Kusakari S, Nawa M, Sudo K, Matsuoka M. Calmodulin-like skin protein protects against spatial learning impairment in a mouse model of Alzheimer disease. J Neurochem. 2018, 144:218-33. 10.1111\/jnc.14258","journal-title":"J Neurochem"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/BF02172188","article-title":"A new puffing pattern induced by temperature shock and DNP in drosophila","volume":"18","author":"Ritossa F","year":"1962","unstructured":"Ritossa F. A new puffing pattern induced by temperature shock and DNP in drosophila. Experientia. 1962, 18:571-3. 10.1007\/BF02172188","journal-title":"Experientia"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1177\/002215549804601109","article-title":"Expression of heat shock proteins in mouse skin during wound healing","volume":"46","author":"Laplante AF","year":"1998","unstructured":"Laplante AF, Moulin V, Auger FA, et al.. Expression of heat shock proteins in mouse skin during wound healing. J Histochem Cytochem. 1998, 46:1291-301. 10.1177\/002215549804601109","journal-title":"J Histochem Cytochem"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1177\/0891988703256051","article-title":"HSP70-2 (HSPA1B) is associated with noncognitive symptoms in late-onset Alzheimer's disease","volume":"16","author":"Clarim\u00f3n J","year":"2003","unstructured":"Clarim\u00f3n J, Bertranpetit J, Boada M, T\u00e0rraga L, Comas D. HSP70-2 (HSPA1B) is associated with noncognitive symptoms in late-onset Alzheimer's disease. J Geriatr Psychiatry Neurol. 2003, 16:146-50. 10.1177\/0891988703256051","journal-title":"J Geriatr Psychiatry Neurol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.cb.11.110195.002301","article-title":"Heat shock transcription factors: structure and regulation","volume":"11","author":"Wu C","year":"1995","unstructured":"Wu C. Heat shock transcription factors: structure and regulation. Annu Rev Cell Dev Biol. 1995, 11:441-69. 10.1146\/annurev.cb.11.110195.002301","journal-title":"Annu Rev Cell Dev Biol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1002\/neu.10269","article-title":"Role of CRMP-2 in neuronal polarity","volume":"58","author":"Arimura N","year":"2004","unstructured":"Arimura N, Menager C, Fukata Y, Kaibuchi K. Role of CRMP-2 in neuronal polarity. J Neurobiol. 2004, 58:34-47. 10.1002\/neu.10269","journal-title":"J Neurobiol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2014.00093","article-title":"The low-density lipoprotein receptor-related protein 1 and amyloid-\u03b2 clearance in Alzheimer\u2019s disease","volume":"6","author":"Kanekiyo T","year":"2014","unstructured":"Kanekiyo T, Bu G. The low-density lipoprotein receptor-related protein 1 and amyloid-\u03b2 clearance in Alzheimer\u2019s disease. Front Aging Neurosci. 2014, 6:93. 10.3389\/fnagi.2014.00093","journal-title":"Front Aging Neurosci"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2010.09.013","article-title":"Oxidative modification to LDL receptor-related protein 1 in hippocampus from subjects with Alzheimer disease: implications for A\u03b2 accumulation in AD brain","volume":"49","author":"Owen JB","year":"2010","unstructured":"Owen JB, Sultana R, Aluise CD, et al.. Oxidative modification to LDL receptor-related protein 1 in hippocampus from subjects with Alzheimer disease: implications for A\u03b2 accumulation in AD brain. Free Radic Biol Med. 2010, 49:1798-803. 10.1016\/j.freeradbiomed.2010.09.013","journal-title":"Free Radic Biol Med"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.neures.2011.09.009","article-title":"Inhibition of mitochondrial permeability transition pore opening is involved in the protective effects of mortalin overexpression against beta-amyloid-induced apoptosis in SH-SY5Y cells","volume":"72","author":"Qu M","year":"2012","unstructured":"Qu M, Zhou Z, Chen C, et al.. Inhibition of mitochondrial permeability transition pore opening is involved in the protective effects of mortalin overexpression against beta-amyloid-induced apoptosis in SH-SY5Y cells. Neurosci Res. 2012, 72:94-102. 10.1016\/j.neures.2011.09.009","journal-title":"Neurosci Res"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3390\/biom2010143","article-title":"Mortalin, apoptosis, and neurodegeneration","volume":"2","author":"Londono C","year":"2012","unstructured":"Londono C, Osorio C, Gama V, Alzate O. Mortalin, apoptosis, and neurodegeneration. Biomolecules. 2012, 2:143-64. 10.3390\/biom2010143","journal-title":"Biomolecules"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2010.10.068","article-title":"Mortalin overexpression attenuates beta-amyloid-induced neurotoxicity in SH-SY5Y cells","volume":"1368","author":"Qu M","year":"2011","unstructured":"Qu M, Zhou Z, Xu S, Chen C, Yu Z, Wang D. Mortalin overexpression attenuates beta-amyloid-induced neurotoxicity in SH-SY5Y cells. Brain Res. 2011, 1368:336-45. 10.1016\/j.brainres.2010.10.068","journal-title":"Brain Res"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1002\/iub.357","article-title":"Neurogranin, a link between calcium\/calmodulin and protein kinase C signaling in synaptic plasticity","volume":"62","author":"D\u00edez-Guerra FJ","year":"2010","unstructured":"D\u00edez-Guerra FJ. Neurogranin, a link between calcium\/calmodulin and protein kinase C signaling in synaptic plasticity. IUBMB Life. 2010, 62:597-606. 10.1002\/iub.357","journal-title":"IUBMB Life"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2008.06.037","article-title":"The effects of retinoic acid on the expression of neurogranin after experimental cerebral ischemia","volume":"1226","author":"Li L","year":"2008","unstructured":"Li L, Li Y, Ji X, Zhang B, Wei H, Luo Y. The effects of retinoic acid on the expression of neurogranin after experimental cerebral ischemia. Brain Res. 2008, 1226:234-40. 10.1016\/j.brainres.2008.06.037","journal-title":"Brain Res"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.2213-04.2004","article-title":"Neurogranin\/RC3 enhances long-term potentiation and learning by promoting calcium-mediated signaling","volume":"24","author":"Huang KP","year":"2004","unstructured":"Huang KP, Huang FL, J\u00e4ger T, Li J, Reymann KG, Balschun D. Neurogranin\/RC3 enhances long-term potentiation and learning by promoting calcium-mediated signaling. J Neurosci. 2004, 24:10660-9. 10.1523\/JNEUROSCI.2213-04.2004","journal-title":"J Neurosci"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awr298","article-title":"Blood-brain barrier P-glycoprotein function in Alzheimer's disease","volume":"135","author":"van Assema DM","year":"2012","unstructured":"van Assema DM, Lubberink M, Bauer M, et al.. Blood-brain barrier P-glycoprotein function in Alzheimer's disease. Brain. 2012, 135:181-9. 10.1093\/brain\/awr298","journal-title":"Brain"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2016.01.013","article-title":"Role of P-glycoprotein in mediating rivastigmine effect on amyloid-\u03b2 brain load and related pathology in Alzheimer's disease mouse model","volume":"1862","author":"Mohamed LA","year":"2016","unstructured":"Mohamed LA, Keller JN, Kaddoumi A. Role of P-glycoprotein in mediating rivastigmine effect on amyloid-\u03b2 brain load and related pathology in Alzheimer's disease mouse model. Biochim Biophys Acta. 2016, 1862:778-87. 10.1016\/j.bbadis.2016.01.013","journal-title":"Biochim Biophys Acta"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurobiolaging.2015.05.020","article-title":"P-glycoprotein expression and amyloid accumulation in human aging and Alzheimer's disease: preliminary observations","volume":"36","author":"Chiu C","year":"2015","unstructured":"Chiu C, Miller MC, Monahan R, Osgood DP, Stopa EG, Silverberg GD. P-glycoprotein expression and amyloid accumulation in human aging and Alzheimer's disease: preliminary observations. Neurobiol Aging. 2015, 36:2475-82. 10.1016\/j.neurobiolaging.2015.05.020","journal-title":"Neurobiol Aging"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1093\/jb\/mvq044","article-title":"Regulatory mechanisms involved in the control of ubiquitin homeostasis","volume":"147","author":"Kimura Y","year":"2010","unstructured":"Kimura Y, Tanaka K. Regulatory mechanisms involved in the control of ubiquitin homeostasis. J Biochem. 2010, 147:793-8. 10.1093\/jb\/mvq044","journal-title":"J Biochem"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(91)91692-T","article-title":"Brain ubiquitin is markedly elevated in Alzheimer disease","volume":"566","author":"Wang GP","year":"1991","unstructured":"Wang GP, Khatoon S, Iqbal K, Grundke-Iqbal I. Brain ubiquitin is markedly elevated in Alzheimer disease. Brain Res. 1991, 566:146-51. 10.1016\/0006-8993(91)91692-T","journal-title":"Brain Res"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3940(87)90698-7","article-title":"Ubiquitin-protein conjugates in Alzheimer\u2019s lesions","volume":"79","author":"Cole GM","year":"1987","unstructured":"Cole GM, Timiras PS. Ubiquitin-protein conjugates in Alzheimer\u2019s lesions. Neurosci Lett. 1987, 79:207-12. 10.1016\/0304-3940(87)90698-7","journal-title":"Neurosci Lett"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroscience.2018.06.018","article-title":"Insulin-signaling pathway regulates the degradation of amyloid \u03b2-protein via astrocytes","volume":"385","author":"Yamamoto N","year":"2018","unstructured":"Yamamoto N, Ishikuro R, Tanida M, Suzuki K, Ikeda-Matsuo Y, Sobue K. Insulin-signaling pathway regulates the degradation of amyloid \u03b2-protein via astrocytes. Neuroscience. 2018, 385:227-36. 10.1016\/j.neuroscience.2018.06.018","journal-title":"Neuroscience"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2018.07.005","article-title":"Biliverdin reductase-A impairment links brain insulin resistance with increased A\u03b2 production in an animal model of aging: implications for Alzheimer disease","volume":"1864","author":"Triani F","year":"2018","unstructured":"Triani F, Tramutola A, Di Domenico F, et al.. Biliverdin reductase-A impairment links brain insulin resistance with increased A\u03b2 production in an animal model of aging: implications for Alzheimer disease. Biochim Biophys Acta Mol Basis Dis. 2018, 1864:3181-94. 10.1016\/j.bbadis.2018.07.005","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0809158106","article-title":"Protection of synapses against Alzheimer's-linked toxins: insulin signaling prevents the pathogenic binding of A\u03b2 oligomers","volume":"106","author":"De Felice FG","year":"2009","unstructured":"De Felice FG, Vieira MN, Bomfim TR, et al.. Protection of synapses against Alzheimer's-linked toxins: insulin signaling prevents the pathogenic binding of A\u03b2 oligomers. Proc Natl Acad Sci U S A. 2009, 106:1971-6. 10.1073\/pnas.0809158106","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2018.01.013","article-title":"Insulin-like growth factor receptor signaling regulates working memory, mitochondrial metabolism, and amyloid-\u03b2 uptake in astrocytes","volume":"9","author":"Logan S","year":"2018","unstructured":"Logan S, Pharaoh GA, Marlin MC, et al.. Insulin-like growth factor receptor signaling regulates working memory, mitochondrial metabolism, and amyloid-\u03b2 uptake in astrocytes. Mol Metab. 2018, 9:141-55. 10.1016\/j.molmet.2018.01.013","journal-title":"Mol Metab"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1016\/0166-2236(88)90195-6","article-title":"Calcium transport and buffering in neurons","volume":"11","author":"Blaustein MP","year":"1988","unstructured":"Blaustein MP. Calcium transport and buffering in neurons. Trends Neurosci. 1988, 11:438-43. 10.1016\/0166-2236(88)90195-6","journal-title":"Trends Neurosci"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1016\/S0306-4522(99)00047-0","article-title":"Subfield- and layer-specific changes in parvalbumin, calretinin and calbindin-D28K immunoreactivity in the entorhinal cortex in Alzheimer\u2019s disease","volume":"92","author":"Mikkonen M","year":"1999","unstructured":"Mikkonen M, Alafuzoff I, Tapiola T, Soininen H, Miettinen R. Subfield- and layer-specific changes in parvalbumin, calretinin and calbindin-D28K immunoreactivity in the entorhinal cortex in Alzheimer\u2019s disease. Neuroscience. 1999, 92:515-32. 10.1016\/S0306-4522(99)00047-0","journal-title":"Neuroscience"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3940(93)90504-E","article-title":"Calretinin-immunoreactive neocortical interneurons are unaffected in Alzheimer\u2019s disease","volume":"152","author":"Hof PR","year":"1993","unstructured":"Hof PR, Nimchinsky EA, Celio MR, Bouras C, Morrison JH. Calretinin-immunoreactive neocortical interneurons are unaffected in Alzheimer\u2019s disease. Neurosci Lett. 1993, 152:145-9. 10.1016\/0304-3940(93)90504-E","journal-title":"Neurosci Lett"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/106410-a-review-of-proteins-associated-with-neuroprotection-and-regeneration-in-alzheimers-disease","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:51:51Z","timestamp":1707508311000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/106410-a-review-of-proteins-associated-with-neuroprotection-and-regeneration-in-alzheimers-disease"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,18]]},"references-count":36,"URL":"https:\/\/doi.org\/10.7759\/cureus.30412","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10,18]]}}}